Literature DB >> 12969701

Reproductive aging and variability in the ovarian antral follicle count: application in the clinical setting.

Karl R Hansen1, Jamie L Morris, Angela C Thyer, Michael R Soules.   

Abstract

OBJECTIVE: To determine the extent of intercycle and interobserver variability in antral follicle (AF) count and their impact on stimulation quality in IVF.
DESIGN: Prospective evaluation of the impact on AF count of GnRH agonist down-regulation and interobserver variability. Retrospective evaluation of intercycle variability in AF count.
SETTING: University ART clinic. PATIENT(S): Twenty subjects were used to evaluate the effect of GnRH agonist down-regulation upon AF count; six of whom were used to evaluate interobserver variability. Fifty patients experiencing two or three cycles of IVF within a 1-year interval. INTERVENTION(S): Transvaginal ultrasound exams before and after down-regulation with a GnRH agonist. Videotaped day-3 transvaginal ultrasound exams. MAIN OUTCOME MEASURE(S): [1] Intercycle and interobserver variability in antral follicle count. [2] Oocytes retrieved, peak estradiol, gonadotropin dose, duration of stimulation and cancellation rates. RESULT(S): There is moderate intercycle and interobserver variability in AF counts. GnRH agonist down-regulation does not significantly change AF count. In infertility patients undergoing IVF, paired analysis between the low- and high-AF count cycles did not show a difference in quality of stimulation or cycle cancellation rates.
CONCLUSIONS: Within an individual patient, higher AF count in a given cycle was not predictive of better stimulation compared with the case of a lower count cycle.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12969701     DOI: 10.1016/s0015-0282(03)00741-6

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  14 in total

1.  Executive summary of the Stages of Reproductive Aging Workshop + 10: addressing the unfinished agenda of staging reproductive aging.

Authors:  Siobán D Harlow; Margery Gass; Janet E Hall; Roger Lobo; Pauline Maki; Robert W Rebar; Sherry Sherman; Patrick M Sluss; Tobie J de Villiers
Journal:  J Clin Endocrinol Metab       Date:  2012-02-16       Impact factor: 5.958

2.  Antral follice counts (AFC) predict ovarian response and pregnancy outcomes in oocyte donation cycles.

Authors:  Alaina Vrontikis; Peter L Chang; Peter Kovacs; Steven R Lindheim
Journal:  J Assist Reprod Genet       Date:  2010-05-14       Impact factor: 3.412

3.  Prediction of high ovarian response to controlled ovarian hyperstimulation: anti-Müllerian hormone versus small antral follicle count (2-6 mm).

Authors:  Abbas Aflatoonian; Homa Oskouian; Shahnaz Ahmadi; Leila Oskouian
Journal:  J Assist Reprod Genet       Date:  2009-06-20       Impact factor: 3.412

4.  Serum anti-Müllerian hormone and antral follicle count as predictive markers of OHSS in ART cycles.

Authors:  Pelin Ocal; Sezai Sahmay; Meral Cetin; Tulay Irez; Onur Guralp; Ismail Cepni
Journal:  J Assist Reprod Genet       Date:  2011-09-01       Impact factor: 3.412

5.  Executive summary of the Stages of Reproductive Aging Workshop + 10: addressing the unfinished agenda of staging reproductive aging.

Authors:  Siobán D Harlow; Margery Gass; Janet E Hall; Roger Lobo; Pauline Maki; Robert W Rebar; Sherry Sherman; Patrick M Sluss; Tobie J de Villiers
Journal:  Fertil Steril       Date:  2012-02-16       Impact factor: 7.329

6.  Executive summary of the Stages of Reproductive Aging Workshop + 10: addressing the unfinished agenda of staging reproductive aging.

Authors:  Siobán D Harlow; Margery Gass; Janet E Hall; Roger Lobo; Pauline Maki; Robert W Rebar; Sherry Sherman; Patrick M Sluss; Tobie J de Villiers
Journal:  Menopause       Date:  2012-04       Impact factor: 2.953

7.  Ovarian senescence in the rhesus monkey (Macaca mulatta).

Authors:  S M Nichols; B D Bavister; C A Brenner; P J Didier; R M Harrison; H M Kubisch
Journal:  Hum Reprod       Date:  2004-10-21       Impact factor: 6.918

8.  Diagnosis and treatment of diminished ovarian reserve in assisted reproductive technology cycles of women up to age 40 years: the role of insurance mandates.

Authors:  Samantha F Butts; Sarah Ratcliffe; Anuja Dokras; David B Seifer
Journal:  Fertil Steril       Date:  2012-10-23       Impact factor: 7.329

9.  Executive summary of the Stages of Reproductive Aging Workshop +10: addressing the unfinished agenda of staging reproductive aging.

Authors:  Siobán D Harlow; Margery Gass; Janet E Hall; Roger Lobo; Pauline Maki; Robert W Rebar; Sherry Sherman; Patrick M Sluss; Tobie J de Villiers
Journal:  Climacteric       Date:  2012-02-16       Impact factor: 3.005

Review 10.  Biological versus chronological ovarian age: implications for assisted reproductive technology.

Authors:  Carlo Alviggi; Peter Humaidan; Colin M Howles; Donald Tredway; Stephen G Hillier
Journal:  Reprod Biol Endocrinol       Date:  2009-09-22       Impact factor: 5.211

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.